Live feed
Filing
SC 13D/A
SC 13D/A0001144204-19-030116·BAKER BROS. ADVISORS LP
Schedule 13D ownership disclosure
Idera Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 45168K405
Event date: 2019-06-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,898,847
- Percent of class
- 17.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-030116
- Form type
- SC 13D/A
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Jun 06, 2019
- Reporting period
- Jun 04, 2019
- Description
- Schedule 13D beneficial ownership